The temple of doom, page-8

The latest announcement was a tad dissapointing but hardly a reason to abandon the stock at near it's cash asset value. IMO the stock is being handled by day traders and I think manipulated by just barely legal trading. The stock is tightly held by the top 20, none of which to my knowledge are sellers, rather, one is a big buyer. Patrys' intellectual property would be valued at many multiples of its' curret share price. It has multiple patents and highly beneficial orphan status in America and Europe. It is developing diagnostics as well as its' PAT series. It is established on 3 continents. It is highly regarded by its' peers. It has many successfull clinical trials to its' credit. It has an important clinical trial being prepared the success of which would most probably result in accreditation for use. It also has several million dollars.